CN202631547U - Lipoprotein a measurement kit - Google Patents
Lipoprotein a measurement kit Download PDFInfo
- Publication number
- CN202631547U CN202631547U CN 201220193852 CN201220193852U CN202631547U CN 202631547 U CN202631547 U CN 202631547U CN 201220193852 CN201220193852 CN 201220193852 CN 201220193852 U CN201220193852 U CN 201220193852U CN 202631547 U CN202631547 U CN 202631547U
- Authority
- CN
- China
- Prior art keywords
- container
- bottle cap
- lipoprotein
- close
- open
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
A lipoprotein a measurement kit comprises a body and a bottle cap, and is characterized in that the body is sequentially provided with a first container, a second container and a third container, and the first container, the second container and the third container are arranged in Chinese character 'yi' mode and is sequentially reduced in volume. Correspondingly, the bottle cap comprises a first bottle cap used to open and close the first container, a second bottle cap used to open and close the second container and a third bottle cap used to open and close the third container. Compared with the prior art, the lipoprotein a measurement kit has the advantages of being simple in structure and convenient to carry. Meanwhile, the lipoprotein a measurement kit can be used in various automation analysis meters and is beneficial for quick measurement.
Description
Technical field
The utility model relates to a kind of kit, and this kit is applied to measure lipoprotein a.
Background technology
1963; The Norway geneticist Berg in Northern Europe is with experimenter's human ldl (LDL) immunizing rabbit; Produce a kind of antiserum to certain antigenic component in the LDL component, Berg (is called for short this newfound antigenic component called after lipoprotein a: Lp (a)).1972, Dalhen etc. found that at first the plasma lipoprotein of many patients with coronary heart disease has a prebeta-lipoprotein in composing, and confirmed that this district's band is Lp (a).Researchs such as Dahlen in 1975 think that Lp (a) is the risk factor of AS.McLean in 1987 etc. discover that apo (a) and plasminogen (PLG) have high homology, and it increases to have and causes thrombotic tendency.Level just is the important independent hazard factor of atherosclerotic cardio-cerebral diseases in Lp (a) body.To morbidity, the change of illness state of coronary heart disease, acute myocardial infarction and lapse to and have diagnostic value.
Early detection Lp (a) electrophoresis of using observe whether occur extra Lp (a) district band between b and the preceding b lipoprotein, but this method sensitivity are low, is used for qualitative detection more more.Develop immunochemistry detection methods that some directly measure Lp (a) subsequently in succession, like radial immunodiffusion (RID), electroimmunodiffusion (EID), radioimmunoassay (RIA), EUSA (ELISA), immune turbidimetry [comprising immune scattering turbidimetry (INA) and immune turbidimetry (ITA)], enhancing part fluorescence immunoassay (DELFIA) etc. dissociates.RID method and EID method do not need specific installation because of easy and simple to handle, still have some grass-roots units laboratories to adopt, but that shortcoming is sensitivity is low.The shortcoming of RIA method is a complicated operation, and radionuclide contamination is arranged.The DELFIA method is used more restricted because of the need specific apparatus.
The utility model content
The utility model technical matters to be solved is that a kind of mensuration lipoprotein a mensuration kit quickly and accurately is provided to the above-mentioned state of the art.
The utility model solves the problems of the technologies described above the technical scheme that is adopted: a kind of lipoprotein a measures kit; It is characterized in that comprising body and bottle cap; It is characterized in that forming successively in the described body first container, second container and the 3rd container; And aforesaid first container, second container and the 3rd container are in-line to be arranged, and capacity successively decreases successively; Accordingly, described bottle cap comprises first bottle cap that is used to open and close first container, the 3rd bottle cap that is used to open and close second bottle cap of second container and is used to open and close the 3rd container.
Further, all has dowel between described first container and second container and second container and the 3rd container.
As preferably, the unit bottle that can throw off can adaptively be arranged in described second container, and described second bottle cap is located at this unit bottle port.Further, the outer wall of said unit bottle has a stopper slot from top to bottom, and accordingly, described second container inner wall has and the spacing spacing muscle that cooperates of aforementioned stopper slot.
First container is placed first reagent; Second container is used to place second reagent; The 3rd container is as complementary tank, and first reagent comprises that the PBS damping fluid of 50mmol/L and the nitrine of 0.95g/L receive, and second reagent comprises that the latex particle that is coated with LP9 (a) antibody and the nitrine of 0.95g/L receive.
Compared with prior art, the advantage of the utility model is: kit is simple in structure, is easy to carry, and simultaneously, can be used for multiple automated analysis appearance, is beneficial to fast detecting.
Description of drawings
Fig. 1 is an embodiment synoptic diagram as a result.
Fig. 2 is the exploded of Fig. 1.
Embodiment
Embodiment describes in further detail the utility model below in conjunction with accompanying drawing.
As depicted in figs. 1 and 2; Lipoprotein a in the present embodiment measures kit and comprises and form first container 1, second container 2 and the 3rd container 3 in body and the body of the bottle lid successively; And first container 1, second container 2 and the 3rd container 3 are in-line to be arranged, and capacity successively decreases successively; Accordingly, bottle cap comprises first bottle cap 11 that is used to open and close first container 1, the 3rd bottle cap 13 that is used to open and close second bottle cap 12 of second container 2 and is used to open and close the 3rd container 3.
All has dowel 4 between first container 1 and second container 2 and second container 2 and the 3rd container 3.The one unit bottle 5 that can throw off can adaptively be arranged in second container 2, and second bottle cap 12 is located at this unit bottle 5 ports.Further, the outer wall of unit bottle 5 has a stopper slot 51 from top to bottom, and accordingly, second container, 2 inwalls have and the stopper slot 51 spacing spacing muscle 6 that cooperate.
First container is placed first reagent; Second container is used to place second reagent; The 3rd container is as complementary tank, and first reagent comprises that the PBS damping fluid of 50mmol/L and the nitrine of 0.95g/L receive, and second reagent comprises that the latex particle that is coated with LP9 (a) antibody and the nitrine of 0.95g/L receive.
Inspection principle: when being coated with the latex particle of LP (a) antibody and containing the sample mix of LP (a) antigen; Can produce agglutinating reaction; Thereby cause the variation of absorbance; Its size is directly proportional with LP (a) content in the sample, with the comparison of the calibration object of absorption photometric and concentration known, can quantitatively draw the content of LP in the sample (a).
The method of inspection, sample 5 μ l add the one 280 μ l, add second reagent, 70 μ l after 3 ~ 5 minutes, instant reading, after 300 seconds, reading for the second time.Through automatic biochemistry analyzer, obtain the result then, the absorbance wavelength is the 600mn wavelength.
Claims (4)
1. a lipoprotein a measures kit; It is characterized in that comprising body and bottle cap, it is characterized in that forming successively in the described body first container, second container and the 3rd container, and; Aforesaid first container, second container and the 3rd container are in-line and arrange; And capacity successively decreases successively, and accordingly, described bottle cap comprises first bottle cap that is used to open and close first container, the 3rd bottle cap that is used to open and close second bottle cap of second container and is used to open and close the 3rd container.
2. lipoprotein a according to claim 1 measures kit, it is characterized in that all having dowel between described first container and second container and second container and the 3rd container.
3. lipoprotein a according to claim 1 measures kit, it is characterized in that adaptively having in described second container unit bottle that can throw off, and described second bottle cap is located at this unit bottle port.
4. lipoprotein a according to claim 3 measures kit, it is characterized in that the outer wall of said unit bottle has a stopper slot from top to bottom, and accordingly, described second container inner wall has and the spacing spacing muscle that cooperates of aforementioned stopper slot.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201220193852 CN202631547U (en) | 2012-04-28 | 2012-04-28 | Lipoprotein a measurement kit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201220193852 CN202631547U (en) | 2012-04-28 | 2012-04-28 | Lipoprotein a measurement kit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN202631547U true CN202631547U (en) | 2012-12-26 |
Family
ID=47384738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201220193852 Expired - Fee Related CN202631547U (en) | 2012-04-28 | 2012-04-28 | Lipoprotein a measurement kit |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN202631547U (en) |
-
2012
- 2012-04-28 CN CN 201220193852 patent/CN202631547U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101915849B (en) | Agent ,which is convenient for sampling, for measuring glycosylated hemoglobin percentage | |
| CN103575913B (en) | The urinalysis test card of microdose urine protein/UCr | |
| WO2011057025A3 (en) | Methods and devices to enhance sensitivity and evaluate sample adequacy and reagent reactivity in rapid lateral flow immunoassays | |
| CN103837674A (en) | Method for detecting specific IgE antibody, kit used in method and preparation and using methods for kit | |
| CN204287206U (en) | NT-proBNP precursor immunochromatographiassay assay quantitative detection test paper | |
| JPS6447951A (en) | Immunoassay method and kit for hapten detection by agglutination | |
| CN104090110A (en) | Colloidal gold immunochromatography test strip for measuring heavy metal cadmium and preparation method thereof | |
| CN110160819A (en) | Fecal specimens are collected and extraction element | |
| WO2012092708A1 (en) | Method and reagent device for determining anti-ra33 antibody igg | |
| CN202631547U (en) | Lipoprotein a measurement kit | |
| CN105891194A (en) | Anticardiolipin antibody IgG chemiluminescence immunoassay kit and preparation method thereof | |
| CN104237230B (en) | The quick determination method of epiphysin and its operation vessel combination | |
| CN204287198U (en) | Omnidistance C reactive protein immunochromatographiassay assay quantitative detection test paper | |
| CN203929780U (en) | A kind of magnetic microparticle chemiluminescence immunity detection reagent of Clenbuterol | |
| CN207502542U (en) | A kind of detection kit for colloidal gold method | |
| CN205581117U (en) | Beta - drug -testing card | |
| CN104142406A (en) | Stable troponin I detection kit | |
| CN209542626U (en) | A kind of Seperated multiple channel chromatographic apparatus | |
| CN202939178U (en) | Multi-piston trace reagent charging device | |
| CN203798733U (en) | POCT (Point of Care Testing) specific protein analysis system | |
| CN102565387B (en) | Kit used for on-site rapid immunodetection and detection method thereof | |
| CN105929151A (en) | Chemiluminiscence immune detection kit for homologous isomer of prostate-specific antigen and preparation method of chemiluminiscence immune detection kit | |
| CN201535775U (en) | Stilboestrol ELISA detection regent kit | |
| CN103293325A (en) | Detection cell system for full-automatic C reaction protein detection instrument or full-automatic ultrasensitive C reaction protein analysis instrument | |
| CN201707334U (en) | Device for implementing immune nano particle chromatographic determination method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CP03 | Change of name, title or address |
Address after: Tonghui Road, Jiangbei investment 315033 in Zhejiang province Ningbo city business center C District No. 999 Patentee after: Ningbo Purui Bai biotechnology Limited by Share Ltd Address before: 315033 Jiangbei District, Zhejiang, Ningbo investment and entrepreneurship center C Patentee before: PUREBIO LABORATORIES (NINGBO) LTD. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121226 Termination date: 20200428 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |